Research Archives - Norton Healthcare Provider

Phase 1 clinical trials update

Clinical research, including clinical trials, is a crucial component to advancing the discovery of cancer therapeutics. Norton Cancer Institute contributes to this advancement through participation in numerous clinical trials every year. 4 phases of clinical [...]

Norton Research Institute unveils state-of-the-art research laboratory

Norton Research Institute will expand research efforts with the unveiling of the new Norton Research Institute Clinical & Translational Research Laboratory. The 7,200-square-foot facility, located inside Norton Healthcare Pavilion in downtown Louisville, will afford ample space […]

Reducing risk of robot-assisted sacroiliac joint fusion complications

Robot-assisted sacroiliac joint (SIJ) fusion surgery can, in about 1% of cases, injure the superior gluteal artery (SGA), but preoperative imaging, precise robot-assisted screw insertion and soft tissue protection can mitigate risks, according to a […]

Ways to make prescribing controlled substances safer

Safer controlled substance prescribing begins with a thorough patient workup, an appropriate diagnosis and a comprehensive treatment plan, according to Kelly C. Cooper, M.D., an addiction medicine specialist with Norton Behavioral Medicine. “We just tend [...]

A case study comparing a pulmonology consult with ChatGPT results

Artificial intelligence (AI) like ChatGPT can compose essays or emails, write computer code, even generate art, but how well can it manage complex patient care? A team that included Norton Healthcare researchers decided to find […]

Phase 1 cystic fibrosis trial studying novel enzyme replacement therapy in adults

Patients 18 years of age and older with cystic fibrosis now have an option of participating in a Phase 1 trial of a novel, broad-spectrum, orally delivered enzyme replacement therapy for cystic fibrosis (CF). The [...]

Open-access, peer-reviewed medical journal accepting submissions

Norton Healthcare has launched a new, open-access medical journal to promote the sharing of innovation and ideas from the laboratory, the bedside and everyday practice. Norton Healthcare Medical Journal welcomes original articles related to medicine, […]

Louisville Business First has recognized Norton Healthcare and Norton Children’s research team members with its 2024 Health Care Heroes Innovator Award

Louisville Business First has recognized researchers at Norton Healthcare with its 2024 Health Care Heroes Innovator Award. The award honors those who break ground in the health care field by developing or implementing new technology, [...]

Butyrate-producing gut bacteria a promising avenue for Alzheimer’s treatment

Butyrate-producing gut bacteria are a promising target for preventing and treating memory loss associated with Alzheimer’s disease, according to research presented recently at the Alzheimer’s Association International Conference (AAIC) in Amsterdam, Netherlands. The research in […]

Natural killer cell leukemia trial underway

A human Phase 1 immunotherapy clinical trial is underway using natural killer cells, or NK cells, to target relapsed or refractory acute myeloid leukemia. Acute myeloid leukemia patients who have exhausted other treatment options are [...]

Glioblastoma immunotherapeutic SurVaxM studied at Norton Healthcare Brain Tumor Center

Researchers at the Norton Healthcare Brain Tumor Center are conducting a clinical trial to determine whether a promising new immunotherapy drug, SurVaxM, improves survivability of glioblastoma. SurVaxM targets survivin, a protein in 95% of glioblastomas [...]

Gilteritinib and venetoclax regimen yields encouraging results against FLT3-mutated AML

A new regimen of FMS-related tyrosine kinase 3 (FLT3) inhibitor gilteritinib and venetoclax was tolerable at standard doses and produced high response rates for advanced, FLT3-mutated acute myeloid leukemia (AML) in a multicenter Phase 1 [...]

Category: Research